Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Julie Ann Dopheide, PharmD

    TitleProfessor of Clinical Pharmacy
    SchoolSchool of Pharmacy
    DepartmentClinical Pharmacy and Pharmaceutical Econ. and Policy
    AddressPSC 602
    Health Sciences Campus
    Los Angeles California 90089-9121
    Phone+1 323 442 1454
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Research Interest
      Dr. Dopheide's work focuses on clinical research involving inpatients with psychiatric illness and expanding roles for psychiatric pharmacists in primary care settings. She has investigated the tolerability of Depakote loading in patients with bipolar disorder and has examined the use of psychotropic medications in hospitalized persons with eating disorders. Dr. Dopheide has collaborated with her PGY-2 psychiatric pharmacy residents to demonstrate the value of integrating psychiatric pharmacists into the medical home to provide comprehensive medication management for patients with both psychiatric and medical conditions.

      Dr. Dopheide has published over 40 articles in peer-reviewed journals, textbooks and educational publications, on topics including ADHD, depression, sleep, insomnia and drug-induced psychiatric disorders.

      Dr. Dopheide is a Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences at the University of Southern California School of Pharmacy, and Keck School of Medicine. She is actively involved in teaching pharmacy students, medical students and psychiatry and pharmacy residents through didactic and clinical teaching.

      Dr. Dopheide’s clinical practice is divided between adults, adolescents and children with psychiatric illness. She serves on Los Angeles County’s department of mental health pediatric psychotropic guideline development committee. As part of a multidisciplinary treatment team, Dr. Dopheide makes recommendations to optimize treatment for psychiatric illnesses including schizophrenia, mood disorders, anxiety, attention-deficit hyperactivity disorder, chronic insomnia and substance abuse.

      Dr. Dopheide is the immediate past president of the College of Psychiatric and Neurologic Pharmacists (CPNP). She is also actively involved with the American Society of Health System Pharmacist’s (ASHP), the American Pharmacists Association, and the National Alliance of the Mentally (NAMI). She is the PGY2 psychiatric pharmacy residency program director and supervises the resident in providing medication therapy management for outpatients in the Center for Community Health safety net clinic located in downtown Los Angeles.

      Dr. Dopheide obtained her PharmD from the University of Nebraska College of Pharmacy in Omaha and went on to complete a residency in Psychiatric Pharmacy Practice at the University of Southern California Medical Center. She has over 40 publications on topics in psychopharmacology and clinical pharmacy. A Nebraska native, she now considers Southern California her home and enjoys rooting for both the Cornhuskers and the Trojans during football season.

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Gomez S, Dopheide J. Antipsychotic Selection for Acute Agitation and Time to Repeat Use in a Psychiatric Emergency Department. J Psychiatr Pract. 2016 Nov; 22(6):450-458. PMID: 27824777.
        View in: PubMed
      2. Stutzman D, Dopheide J. Acetylcysteine for treatment of autism spectrum disorder symptoms. Am J Health Syst Pharm. 2015 Nov 15; 72(22):1956-9. PMID: 26541950.
        View in: PubMed
      3. Williams AM, Dopheide J. Nonpsychiatric medication interventions initiated by a postgraduate year 2 psychiatric pharmacy resident in a patient-centered medical home. Prim Care Companion CNS Disord. 2014; 16(6). PMID: 25834765; PMCID: PMC4374824.
      4. Nazarian PK, Dopheide J. Psychiatric pharmacist management of depression in patients with diabetes. Prim Care Companion CNS Disord. 2013; 15(5). PMID: 24511443; PMCID: PMC3907323.
      5. Dopheide J. Vilazodone's comparative merits yet to be demonstrated. Am J Health Syst Pharm. 2012 Sep 15; 69(18):1549. PMID: 22935936.
        View in: PubMed
      6. Wang I, Dopheide J, Gregerson P. Role of a psychiatric pharmacist in a Los Angeles "Skid-Row" safety-net clinic. J Urban Health. 2011 Aug; 88(4):718-23. PMID: 21512832; PMCID: PMC3157501.
      7. Chung B, Dopheide J, Gregerson P. Psychiatric pharmacist and primary care collaboration at a skid-row safety-net clinic. J Natl Med Assoc. 2011 Jul; 103(7):567-74. PMID: 21999031.
        View in: PubMed
      8. Dopheide J. Iloperidone: Does it have a meaningful place in therapy? Am J Health Syst Pharm. 2011 Feb 15; 68(4):297. PMID: 21289322.
        View in: PubMed
      9. Dopheide J, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy. 2009 Jun; 29(6):656-79. PMID: 19476419.
        View in: PubMed
      10. Dopheide J. The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. Am J Manag Care. 2009 May; 15(5 Suppl):S141-50. PMID: 19601689.
        View in: PubMed
      11. Dopheide J. Paliperidone: An improvement over risperidone? Am J Health Syst Pharm. 2008 Mar 01; 65(5):401. PMID: 18281730.
        View in: PubMed
      12. Knox ED, Dopheide J, Wincor MZ, Han PK. Depression screening in a university campus pharmacy: a pilot project. J Am Pharm Assoc (2003). 2006 Jul-Aug; 46(4):502-6. PMID: 16913394.
        View in: PubMed
      13. Dopheide J. Recognizing and treating depression in children and adolescents. Am J Health Syst Pharm. 2006 Feb 01; 63(3):233-43. PMID: 16434782.
        View in: PubMed
      14. Gable KN, Dopheide J. Psychotropic medication use at a private eating disorders treatment facility: A retrospective chart review and descriptive data analysis. Curr Ther Res Clin Exp. 2005 Nov; 66(6):572-88. PMID: 24764595; PMCID: PMC3997119.
      15. Dopheide J. ASHP therapeutic position statement on the appropriate use of medications in the treatment of attention-deficit/hyperactivity disorder in pediatric patients. Am J Health Syst Pharm. 2005 Jul 15; 62(14):1502-9. PMID: 15998933.
        View in: PubMed
      16. Park SH, Gill MA, Dopheide J. Visual compatibility of risperidone solution and lithium citrate syrup. Am J Health Syst Pharm. 2003 Mar 15; 60(6):612-3. PMID: 12659069.
        View in: PubMed
      17. Roe KK, Dopheide J, Wincor MZ. Developing a partnership with NAMI and psychiatric pharmacists. Schizophr Bull. 2002; 28(3):525-9. PMID: 12645683.
        View in: PubMed
      Julie's Networks
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Similar People
      People who share similar concepts with this person.
      Same Department